Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 67 (4), 655-69

Intra-brain Microinjection of Human Mesenchymal Stem Cells Decreases Allodynia in Neuropathic Mice

Affiliations

Intra-brain Microinjection of Human Mesenchymal Stem Cells Decreases Allodynia in Neuropathic Mice

Dario Siniscalco et al. Cell Mol Life Sci.

Abstract

Neuropathic pain is a very complex disease, involving several molecular pathways. Current available drugs are usually not acting on the several mechanisms underlying the generation and propagation of pain. We used spared nerve injury model of neuropathic pain to assess the possible use of human mesenchymal stem cells (hMSCs) as anti-neuropathic tool. Human MSCs were transplanted in the mouse lateral cerebral ventricle. Stem cells injection was performed 4 days after sciatic nerve surgery. Neuropathic mice were monitored 7, 10, 14, 17, and 21 days after surgery. hMSCs were able to reduce pain-like behaviors, such as mechanical allodynia and thermal hyperalgesia, once transplanted in cerebral ventricle. Anti-nociceptive effect was detectable from day 10 after surgery (6 days post cell injection). Human MSCs reduced the mRNA levels of the pro-inflammatory interleukin IL-1beta mouse gene, as well as the neural beta-galactosidase over-activation in prefrontal cortex of SNI mice. Transplanted hMSCs were able to reduce astrocytic and microglial cell activation.

Similar articles

See all similar articles

Cited by 35 PubMed Central articles

See all "Cited by" articles

References

    1. J Neurosci. 2007 May 30;27(22):6006-18 - PubMed
    1. Eur J Neurosci. 2008 Mar;27(5):1051-60 - PubMed
    1. Cell Transplant. 2006;15(8-9):711-21 - PubMed
    1. Neurosurgery. 2001 Nov;49(5):1196-203; discussion 1203-4 - PubMed
    1. Zhonghua Yi Xue Za Zhi. 2007 Mar 27;87(12):847-50 - PubMed

LinkOut - more resources

Feedback